NCT03736993View on ClinicalTrials.gov

Metabolomics Predict Therapy Response

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 28, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
NSCLC, Stage IIIA
Interventions
OTHER

Additional blood sampling

Establish predictive markers for early disease progression after complete surgical resection in patients with stage I to IIIA NSCLC.

Trial Locations (4)

3600

Ziekenhuis Oost-Limburg, Genk

8800

AZ Delta, Roeselare

9000

UZ Gent, Ghent

Unknown

OLV ziekenhuis Aalst, Aalst

All Listed Sponsors
collaborator

Ziekenhuis Oost-Limburg

OTHER

lead

Hasselt University

OTHER

NCT03736993 - Metabolomics Predict Therapy Response | Biotech Hunter | Biotech Hunter